Kyntra Bio, Inc.
Pharmaceutical company · San Francisco, California, United States · Nasdaq: KYNB
Kyntra Bio, Inc. is a pharmaceutical company headquartered in San Francisco, California, United States. Its shares trade on Nasdaq under the ticker KYNB. It has received 5 US government small-business research awards (SBIR/STTR) from health agencies, $1.2 million in total, most recently in 2006. It has reported private securities offerings to the US SEC, most recently $20 million sold in a notice filed in 2014.
Kyntra Bio at a glance
What does Kyntra Bio do?
US government research funding
5 SBIR/STTR small-business research awards from US health agencies, $1.2 million in total (1996 to 2006).
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $20 million sold (2014).
Frequently asked questions about Kyntra Bio
Where is Kyntra Bio headquartered?
Kyntra Bio, Inc. is headquartered in San Francisco, California, United States.
What does Kyntra Bio do?
Kyntra Bio, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is Kyntra Bio a public company?
Yes. Kyntra Bio, Inc. trades on Nasdaq under the ticker KYNB.
Similar companies
- Nektar TherapeuticsSan Francisco, California, United States
- Olema Pharmaceuticals, Inc.San Francisco, California, United States
- GT Biopharma, Inc.San Francisco, California, United States
- AbbVie Inc.North Chicago, Illinois, United States
- Savara IncAustin, Texas, United States
- Crinetics Pharmaceuticals, Inc.San Diego, California, United States
- Cartesian Therapeutics, Inc.Frederick, Maryland, United States
- Karyopharm Therapeutics Inc.Newton, Massachusetts, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.